Skip to content

Evaluation of a New CZT System

Evaluation of a New CZT System for Imaging in Routine Nuclear Medicine Examination

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01084356
Enrollment
100
Registered
2010-03-10
Start date
2010-03-31
Completion date
Unknown
Last updated
2010-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parathyroid Adenoma, Thyroid Adenoma

Keywords

CZT, sentinel node, osseous processes

Brief summary

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use. Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations. The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Interventions

None listed

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age over 18

Exclusion criteria

* pregnancy * patients unable to understand and sign an informed consent * age under 18

Countries

Israel

Contacts

Primary ContactEinat Even Sapir, PhD,MD
evensap@tasmc.health.gov.il972-3-6974444
Backup ContactAyelet Kurzband, BA
ayeletk@tasmc.health.gov.il972-3-6974444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026